Poorhosseini Hamidreza, Mousavi Mehdi, Nematipour Ebrahim, Kassaian Seyed Ebrahim, Salarifar Mojtaba, Alidoosti Mohammad, Hajizeinali Alimohammad, Nozari Younes, Amirzadegan Alireza, Hosseini Seyed Kianoosh, Sheikhfathollahi Mahmood
Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
J Tehran Heart Cent. 2011 Summer;6(3):126-33. Epub 2011 Aug 31.
Clinical trials of revascularization have routinely under-enrolled elderly subjects. Thus, symptom relief and improved survival might not apply to elderly patients, in whom the risk of mortality and disability from revascularization procedures seems to be high and co-morbidity is more prevalent. The present case control study was performed to draw a comparison in terms of the procedural success, procedural and in-hospital complications, and major adverse cardiac events (MACE) in a one-year follow-up of octogenarians (age ≥ 80 years) with a selected matched younger control group in the Tehran Heart Center Angioplasty Registry.
According to the Tehran Heart Center Interventional Registry of 9, 250 patients with a minimum follow-up period of one year between April 1993 and February 2010, 157 percutaneous coronary intervention (PCI) procedures were performed in 112 octogenarians. Additionally, 336 younger patients (459 PCI procedures) were selected from the database as the propensity-score matched controls.
There were 147 (93.6%) and 441 (96.1%) successful PCI procedures in the elderly group and control group, respectively (p value = 0.204). Procedural complications were seen in 5 (3.2%) of the elderly group and 16 (3.5%) of the control group (p value = 0.858). Totally, 7 (6.3%) in-hospital complications occurred in the elderly group and 22 (6.8%) in the control group (p value = 0.866). One-year MACE was seen in 9 (9.1%) of the elderly and 18 (5.8%) of the control group (p value = 0.26).
Procedural success and complications, in-hospital complications, and one-year MACE were not significantly different between our two study groups. Therefore, age alone should not be used as the sole criterion when considering revascularization procedures. Furthermore, PCI should not be refused in octogenarians if indicated.
血管重建术的临床试验通常纳入老年受试者不足。因此,症状缓解和生存率提高可能不适用于老年患者,血管重建术导致的死亡和残疾风险在老年患者中似乎较高,且合并症更为普遍。本病例对照研究旨在比较德黑兰心脏中心血管成形术登记处80岁及以上(年龄≥80岁)的老年人与选定的匹配年轻对照组在一年随访中的手术成功率、手术及院内并发症以及主要不良心脏事件(MACE)。
根据德黑兰心脏中心介入登记处1993年4月至2010年2月期间9250例患者至少一年的随访记录,112名80岁及以上老人接受了157例经皮冠状动脉介入治疗(PCI)。此外,从数据库中选择336名年轻患者(459例PCI)作为倾向评分匹配对照组。
老年组和对照组分别有147例(93.6%)和441例(96.1%)PCI手术成功(p值 = 0.204)。老年组5例(3.2%)和对照组16例(3.5%)出现手术并发症(p值 = 0.858)。老年组共发生7例(6.3%)院内并发症,对照组发生22例(6.8%)(p值 = 0.866)。老年组1年MACE发生率为9例(9.1%),对照组为18例(5.8%)(p值 = 0.26)。
我们的两个研究组在手术成功率、并发症、院内并发症和1年MACE方面无显著差异。因此,在考虑血管重建术时,不应仅以年龄作为唯一标准。此外,如果有指征,不应拒绝80岁及以上老人接受PCI治疗。